2014
GYN SCHOOL JULY 12-14
Westin River North | Chicago, Illinois
Co-Sponsored By:
TARG E T I NG
C A NC E R
C A RE
THE FIRST COMBINED MEETING OF
ABS, ASCO, ASTRO, & SGO
GYN SCHOOL JULY 12-14, 2014
An Invitation to Join Us
Dear Colleagues:
We are pleased to host the FIRST multidisciplinary Gynecologic
Cancers Symposium, led by the American Brachytherapy
Society (ABS), and co-sponsored by ASCO, ASTRO, and SGO,
in Chicago, Illinois, from July 12-14, 2014. This will be the first combined meeting of these distinguished societies and is meant to
foster collaboration between radiation oncologists, gynecologic
oncologists, and medical oncologists.
To begin the meeting, cervical
brachytherapy, intact cervix and
vulvar contouring workshops will be
available for participation on July
12th. There will also be a concurrent difficult brachytherapy case
session to attend. On July 13-14th,
this first multidisciplinary Gynecologic
Cancer Symposium will focus on
“state-of-the-science” topics related
to endometrial, vulvar, and cervical
cancers. Experts from all specialties will participate in these presentations.
Podium and poster abstracts will also
be presented. With this collaborative effort, our hope is to further the
management of patients with gynecologic cancers and also provide a
valuable learning experience for the
physicians who care for them. We
welcome you to Chicago and are
enthusiastic about the initiation of
this collaborative “state- of –thescience” meeting.
Sincerely,
Beth A. Erickson, MD, FACR, FASTRO
Program Co-Chair
Medical College of Wisconsin
Milwaukee, WI
Akila N. Viswanathan, MD, MPH
Program Co-Chair
Dana-Farber Brigham and
Women’s Cancer Care
Boston, MA
GENERAL INFORMATION
ABS Board of Directors
President | David E. Wazer, MD
Vice President | David G. Gaffney, MD, PhD
Secretary | Catheryn M. Yashar, MD
Treasurer | Firas Mourtada, PhD
Chairman | Akila N. Viswanathan, MD, MPH
Board Members-at-Large
Stephen J. Frank, MD
Gerard C. Morton, MD
Mira Keyes, MD, FRCPC
Subir Nag, MD, FACR, FACRO
Who Should Attend?
The target audience for this educational school includes radiation oncologists, medical physicists,
dosimetrists and medical residents practicing in the field of brachytherapy, including those that
wish to learn more about the quality assurance issues in this specific medical specialty.
4
GYN SCHOOL JULY 12-14, 2014
INVITED FACULTY
Nadeem Abu-Rustum, MD, FACOG, FACS
Memorial Sloan Kettering Cancer Center
New York, NY
Carol Aghajanian, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Ronald D. Alvarez, MD
University of Alabama at Birmingham
Birmingham, AL
Jamie N. Bakkum-Gamez, MD
Mayo Clinic
Rochester, MN
Sushil Beriwal, MD
University of Pittsburgh
Pittsburgh, PA
Michael J. Birrer, MD, PhD
Massachusetts General Hospital
Boston, MA
Manjeet Chadha, MD
Beth Israel Medical Center
New York, NY
Junzo P. Chino, MD
Duke University Medical Center
Durham, NC
David E. Cohn, MD
Ohio State University
Columbus, OH
Allan Covens, MD, LMCC, FRCSC
Sunnybrook Health Sciences Centre
Toronto, ON
Paul A. DiSilvestro, MD
Woman & Infants Hospital
Providence, RI
Beth A. Erickson, MD, FACR, FASTRO
Medical College of Wisconsin
Milwaukee, WI
Anthony Fyles, FRCPC, MD
Princess Margaret Cancer Centre
Toronto, ON
David K. Gaffney, MD, PhD
University of Utah
Salt Lake City, UT
Paul Haluska, MD, PhD
Mayo Clinic
Rochester, MN
Matthew M. Harkenrider, MD
Stritch School of Medicine,
Loyola University
Maywood, IL
Westin River North | Chicago, Illinois
Neil S. Horowitz, MD
Dana-Farber Brigham
and Women’s Cancer Care
Boston, MA
Katherine M. Moxley, MD
Peggy and Charles Stephenson Cancer Center
Oklahoma City, OK
Anuja Jhingran, MD
MD Anderson Cancer Center
Houston, TX
Akinyemi I. Ojesina, MD, PhD
Dana-Farber Cancer Institute/Harvard
Medical School
Cambridge, MA
Ann Klopp, MD, PhD
MD Anderson Cancer Center
Houston, TX
Ivy A. Peterson, MD
Mayo Clinic
Rochester, MN
Wui-Jin Koh, MD
University of Washington
Seattle, WA
Matthew A. Powell, MD
Washington University in St. Louis
School of Medicine
St. Louis, MO
Susanna Lee, MD, PhD
Massachusetts General Hospital
Boston, MA
Helen Mackay, MD
Princess Margaret Cancer Center
Toronto, ON
Robert S. Mannel, MD
Peggy and Charles Stephenson
Cancer Center
Oklahoma City, OK
Marcus E. Randall, MD, FACR
University of Kentucky
Lexington, KY
Anthony H. Russell
Massachusetts General Hospital
Boston, MA
Julie Schwartz, MD, PhD
Washington University School of Medicine
St. Louis, MO
Andrea Mariani, MD
Mayo Clinic
Rochester, MN
Brain Slomovitz, MD
Morristown Medical Center
Morristown, NJ
Danielle E Matei, MD
Indiana University Cancer Center
Indianapolis, IN
William Small, Jr., MD, FACRO, FACR, FASTR
Stritch School of Medicine
Loyola University Chicago
Maywood, IL
Ursula Matulonis, MD
Dana-Farber Cancer Institute
Boston, MA
Jyoti S. Mayadev, MD
University of California Davis
Sacramento, CA
Nina Mayr, MD
University of Washington
Seattle, WA
Carolyn McCourt, MD
Woman & Infants Hospital
Providence, RI
David S. Miller, MD, FACOG, FACS
UT Southwestern
Dallas, TX
Kathleen N. Moore, MD
Peggy and Charles Stephenson
Cancer Center
Oklahoma City, OK
Akila N. Viswanathan, MD, MPH
Dana-Farber Brigham
and Women’s Cancer Care
Boston, MA
Joan L. Walker, MD
University of Oklahoma Health
Sciences Center
Oklahoma City, OK
Lari Wenzel, PhD
University of California, Irvine
Irvine, CA
Catheryn M. Yashar, MD
University of California, San Diego
San Diego, CA
The views expressed by speakers
are NOT necessarily the views of
the American Brachytherapy Society.
5
LEARNING
OBJECTIVES
The 2014 ABS GYN School Will Allow Participants to:
1 Describe recent advances in the management of GYN cancer with
brachytherapy
2 Integrate and apply in your daily practice recent ABS GYN brachytherapy
guidelines
3 Apprise recent GYN cancer clinical trials
4 Explain concepts and controversies in management and optimal
use of brachytherapy in endometrial cancer
5 Integrate and apply in daily practice advances in GYN cancer imaging
and their appropriate clinical applications
6 Understand the clinical implications and practical steps to management
of vulvar cancer
7 Formulate and appropriately integrate various imaging modalities
GYN brachytherapy
8 Determine patients selection, planning and clinical outcomes
for endometrial, cervical and vulvar cancer treated with combined
modality therapy
9 Analyze the controversies and appropriate clinical indications for
surgical lymph node dissection in endometrial cancer and sentinel node
dissection in endometrial and vulvar cancer
10 Analyze the controversies and appropriate clinical indications for
combined modality therapy including GYN brachytherapy
11 Analyze and discuss the controversies and appropriate clinical
indications for SBRT vs. GYN brachytherapy
12 Evaluate difficult cases in GYN cancers with audience participation
13 Apprise the role, principles and techniques in cervical cancer
brachytherapy
14 Understand the clinical implications with new advances in clinical
brachytherapy including Image Guided Brachytherapy (IGBT)
15 Understand and apprise integration of new brachytherapy technologies
into the routine practice
Contouring Workshops
6
1
2
Review the normal anatomy relevant for GYN cancer
3
Discuss, review and practice contouring challenging cases.
Discuss how to solve the contouring problems.
4
Critique various imaging modalities and develop practical approach
to overcome imaging limitations.
Be able to accurately contour GTV, CTV and PTV for
GYN cancer planning.
Westin River North | Chicago, Illinois
GYN SCHOOL JULY 12-14, 2014
6
HOTEL & TRAVEL
ACCOMMODATIONS
Westin River North
320 N Dearborn Street, Chicago, IL 60654
To ensure accommodations, please contact
the Westin at 1-800-233-4100 and remember
to identify yourself as an ABS attendee.
The deadline for reservations is June 17, 2014.
You may also book your room on-line at the
ABS website at www.americanbrachytherapy.org.
Airline Reservations
IMPORTANT
DEADLINE
INFORMATION
MEETING Registration
June 20, 2014
HOTEL Reservation
June 21, 2014
For airline and flight options, you may contact:
World Travel, Washington, DC
202-728-4040
Americans with Disabilities Act
Individuals needing auxiliary aids or services as identified
in the Americans with Disabilities Act, please contact:
ABS Executive Director Rick Guggolz
703-234-4078, extension 4070
VISIT THE ABS WEBSITE AT:
americanbrachytherapy.org
MEETING Cancellation
June 30, 2014
*ANY cancellations OR no-shows
AFTER this date will be charged
the full registration fee.
Registration fee can be applied to
a FUTURE ABS educational event.
Westin River North | Chicago, Illinois
7
2014
GYN SCHOOL AGENDA
Saturday, July 12
2:55 pm Welcome to Course
Beth A. Erickson, MD, FACR, FASTRO
ABS Scientific Program Co-Chair
3:00 pm – 4:00 pm Cervix Brachytherapy
Moderator:
Beth A. Erickson, MD, FACR, FASTRO
Medical College of Wisconsin
Milwaukee, WI
3:00 pm – 4:00 pm Difficult Cases in Brachytherapy
Moderator:
William Small Jr., MD, FACRO, FACR, FASTRO
Stritch School of Medicine Loyola University Chicago
Maywood, IL
Panelists:
Junzo P. Chino, MD
Duke University Medical Center
Durham, NC
Matthew M. Harkenrider, MD
Stritch School of Medicine, Loyola University
Maywood, IL
Jyoti S. Mayadev, MD
University of California Davis
Sacramento, CA
4:15 pm – 5:15 pm Intact Cervix Contouring
Catheryn M. Yashar, MD
University of California, San Diego
San Diego, CA
5:15 pm – 6:15 pm Vulvar Contouring
Sushil Beriwal, MD
University of Pittsburgh
Pittsburgh, PA
9
GYN SCHOOL JULY 12-14, 2014
Sunday, July 13
7:00 am – 8:00 am Registration, Breakfast and Vendor Exhibit
7:55 am – 8:00 am Daily Recap
Akila Viswanathan, MD, MPH
Dana-Farber Brigham and Women’s Cancer Care
Boston, MA
SESSION 1 — ENDOMETRIAL CANCER
8:00 am – 9:00 am PANEL I — Pre-Operative Factors
Moderator:
Michael J. Birrer,MD, PhD
Massachusetts General Hospital
Boston, MA
8:00 am – 8:20 am Development of Endometrial Cancer — Risk Factors
and the Biology of Cancer Development
Carolyn McCourt, MD
Woman & Infants Hospital
Providence, RI
8:20 am – 8:40 am Role of Radiologic Imaging for Risk Assessment
Susanna Lee, MD, PhD
Massachusetts General Hospital
Boston, MA
8:40 am – 9:00 am Role of Minimally Invasive Surgery
Paul A. DiSilvestro, MD
Woman & Infants Hospital
Providence, RI
9:00 am -10:00 am PANEL II:
The Management of Lymph Nodes in Endometrial Cancer
Moderator:
Robert S. Mannel, MD
Peggy and Charles Stephenson Cancer Center
Oklahoma City, OK
9:00 am – 9:20 am Sentinel Lymph Node Mapping for Endometrial Cancer
Nadeem R. Abu-Rustum, MD, FACOG, FACS
Memorial Sloan Kettering Cancer Center
New York, NY
9:20 am – 9:30 am Pro: Complete Lymphadenectomy
Ronald D. Alvarez, MD
University of Alabama at Birmingham
Birmingham, AL
Westin River North | Chicago, Illinois
9
Sunday, July 13 (continued)
9:30 am – 9:40 am Con: Lymphadenectomy
Marcus E. Randall, MD, FACR
University of Kentucky
Lexington, KY
9:40 am – 9:50 am Selective: Risk Factors for LN Involvement
Andrea Mariani, MD
Mayo Clinic
Rochester, MN
9:50 am – 10:00 am Panel Discussion
10:00 am -10:15 am Coffee Break
10:15 am – 11:45 am PANEL III:
Endometrial Cancer Treatment
Moderators:
David K. Gaffney, MD, PhD
University of Utah
Salt Lake City, UT
David S. Miller, MD, FACOG, FACS
UT Southwestern University
Dallas, TX
10:15 am – 10:30 am Early Stage Endometrial Cancer:
Observation Versus Brachytherapy
Manjeet Chadha, MD
Beth Israel Medical Center
New York, NY
10:30 am – 10:45 am Brachytherapy Versus External Beam for
Endometrial Cancer
Ann Klopp, MD, PhD
MD Anderson Cancer Center
Houston, TX
10:45 am – 11:00 am What is the Role of Chemotherapy in the Adjuvant Setting
for Stage I-II Disease?
Matthew A. Powell, MD
Washington University in St. Louis School of Medicine
St. Louis, MO
11:00 am – 11:15 am What is the Role of Chemo in the Adjuvant Setting
for Stage III-IVA Disease?
Daniela E. Matei, MD
Indiana University Cancer Center
Indianapolis, IN
11:15 am – 11:30 am Targeted Therapies in the Future — Where are We Now and
Where are We Going?
Carol Aghajanian, MD
Memorial Sloan Kettering Cancer Center
New York, NY
10
GYN SCHOOL JULY 12-14, 2014
11:30 am – 11:45 am Panel Discussion
11:45 am – 12:00 pm Cost Effectiveness
David E. Cohn, MD
Ohio State University
Columbus, OH
12:00 pm - 12:15 pm Late Effects and Quality of Life Following
Aggressive Management
Lari Wenzel, PhD
University of California, Irvine
Irvine, CA
12:15 pm – 1:30 pm Lunch
1:30 pm – 2:00 pm Oral Abstract Presentations
Moderator:
Ursula A. Matulonis, MD
Dana-Farber Brigham and Women’s Cancer Care
Boston, MA
SESSION II — VULVAR CANCER
2:00 pm – 3:30 pm PANEL IV:
Vulvar Cancer Management
Moderators:
David K. Gaffney, MD, PhD
University of Utah
Salt Lake City, UT
Anthony H. Russell, MD
Massachusetts General Hospital
Boston, MA
2:00 pm – 2:15 pm Primary Surgical Approach Using Sentinal Lymph
Node Assessment
Brian Slomovitz, MD
Morristown Medical Center
Morristown, NJ
2:15 pm – 2:30 pm Radiation Instead of Surgery for Lymph Nodes
Wui-Jin Koh, MD
University of Washington
Seattle, WA
2:30 pm – 2:45 pm Pathologic Features and Indications
for Postoperative Therapy
Akila N. Viswanathan, MD, MPH
Dana-Farber Brigham and Women’s Cancer Care
Boston, MA
Westin River North | Chicago, Illinois
11
Sunday, July 13 (continued)
2:45 pm – 3:00 pm Treatment Role of Radiation and Chemo
in Locally Advanced Disease
Neil S. Horowitz, MD
Dana-Farber Brigham and Women’s Cancer Care
Boston, MA
3:00 pm – 3:15 pm Tissue Issues: Maximizing Cancer Control
While Minimizing Late Sequelae of Treatment
Anthony H. Russell, MD
Massachusetts General Hospital
Boston, MA
3:15 pm – 3:30 pm Biological Therapies in Vulvar Carcinoma
Helen Mackay, MD
Princess Margaret Cancer Center
Toronto, ON
3:30 pm – 3:45 pm Panel Discussion/Questions
3:45 pm – 4:00 pm Coffee Break
4:00 pm – 4:30 pm Oral Abstract Presentations
Moderator:
4:30 pm – 5:00 pm Poster Viewing
5:00 pm – 6:00 pm Welcome Reception
Monday, July 14
7:00 am – 8:00 am Registration, Breakfast and Vendor Exhibit
7:55 am – 8:00 am Daily Recap
8:00 am – 9:00 am SESSION III — CERVICAL CANCER
PANEL V:
Management of Early Stage Cervical Cancer
Moderators:
Paul A. DiSilvestro, MD
Woman & Infants Hospital
Providence, RI
Catheryn M. Yashar, MD
University of California, San Diego
San Diego, CA
12
GYN SCHOOL JULY 12-14, 2014
8:00 am – 8:15 am HPV Where are we Now, Screening and
Vaccination Update
Katherine M. Moxley, MD
Peggy and Charles Stephenson Cancer Center
Oklahoma City, OK
8:15 am – 8:30 am Genetic Alterations in Cervical Cancer
Ayinyemi I. Ojesina, MD, PhD
Dana-Farber Cancer Institute/Harvard Medical School
Cambridge, MA
8:30 am – 8:45 am Conservative Management of Early Cervical Cancer
Allan Covens, MD, LMCC, FRCSC
Sunnybrook Health Sciences Center
Toronto, ON
8:45 am – 9:00 am Surgical Approaches to Cervical Cancer
Joan L. Walker, MD
Oklahoma University Medical Center
Oklahoma City, OK
9:00 am –10:00 am Oral Presentations
Moderator:
Anthony W. Fyles, FRCPC, MD
Princess Margaret Cancer Centre
Toronto, ON
10:00 am –10:15 am Coffee Break
10:15 am –11:30 am PANEL VI:
Management of Cervical Cancer
with Radiation and Chemotherapy
Moderator:
Akila N. Viswanathan
Dana-Farber Brigham and Women’s Cancer Center
Boston, MS
10:15 am – 10:30 am Postoperative Treatment for Intermediate and
High Risk Cervical Cancer
Anuja Jhingran, MD
MD Anderson Cancer Center
Houston, TX
10:30 am – 10:45 am MR imaging in Locally Advanced Cervical Cancer
Nina Mayr, MD
University of Washington
Seattle, WA
10:45 am – 11:00 am PET imaging in Locally Advanced Cervical Cancer
Julie Schwarz, MD, PhD
Washington University School of Medicine
Saint Louis, MO
Westin River North | Chicago, Illinois
13
Monday, July 14 (continued)
11:00 am – 11:15 am Chemotherapy: Treatment Duration and
Outback Chemotherapy
Kathleen N. Moore, MD
Peggy and Charles Stephenson Cancer Center
Oklahoma City, OK
11:15 am – 11:30 am Outcome Results with Image-Based
Intracavitary Brachytherapy
Beth A. Erickson, MD, FACR, FASTRO
Medical College of Wisconsin
Milwaukee, WI
11:30 am – 1:00 pm PANEL VII:
Management of Recurrent Disease
Moderator:
Anthony W. Fyles, FRCPC, MD
Princess Margaret Cancer Centre
Toronto, ON
11:30 am – 11:45 am Surgical Salvage for Recurrence
Jamie N. Bakkum-Gamez, MD
Mayo Clinic
Rochester, MN
11:45 am – 12:00 pm Role of Re-irradiation and Brachytherapy in
Recurrent Cervical Cancer Interstitial Brachytherapy
Akila N. Viswanathan, MD, MPH
Dana-Farber Brigham and Women’s Cancer Care
Boston, MA
12:00 pm – 12:15 pm IORT
Ivy A. Peterson, MD
Mayo Clinic
Rochester, MN
12:15 pm – 12:30 pm SBRT
Charles Kunos, MD, PhD
Summa Cancer Institute
Akron, OH
12:30 pm – 1:00 pm Palliative Chemotherapy Approaches to
Recurrent Disease and Novel Biologic Therapies
Paul Haluska, MD, PhD
Mayo Clinic
Rochester, MN
1:00 pm Meeting Adjourn
14
GYN SCHOOL JULY 12-14, 2014
The American Brachytherapy Society (ABS)
Invites
You
to Join Our Association
The American Brachytherapy Society was
founded in 1978 to provide insight, rationale,
and research into the use of brachytherapy
in the treatment of both malignant and be-
Future ABS Meetings
2014 ABS
Prostate School
July 11–12, 2014
Westin North River
Chicago, IL
nign conditions. The organization consists of
physicians, physicists, and other health care
professionals interested in brachytherapy.
The purpose of the ABS is to serve its members by advancing the field of brachytherapy, by promoting excellence in education,
research and clinical practice, and by representing brachytherapy specialists and
their patients. For more information on the
2015 ABS
Annual Meeting
April 9–11, 2015
Renaissance Orlando
Orlando, FL
ABS and a membership application, visit
www.americanbrachytherapy.org.
ABS Sponsors:
Platinum Level
2016 World
Congress
June 27–29, 2016
San Francisco Hilton
San Francisco, CA
Bronze Level
American Brachytherapy Society
12100 Sunset Hills Road | Suite 130 | Reston, VA 20190
P 703.234.4078 | F 703.435.4390
www.americanbrachytherapy.org
ABS National Office
12100 Sunset Hills Road | Suite 130 | Reston, VA 20190
tel: 703.234.4078 | ext. 4085, 4070, or 4071
fax: 703.435.4390
americanbrachytherapy.org